SFA Therapeutics, Inc., a clinical-stage biopharmaceutical company developing oral small-molecule biosynthetic compounds for ...

In this medical fiction tale, a journalist's attempt to expose what he believes to be a secret gender-affirming care clinic in a hospital basement turns deadly.

The new drug application resubmission of rivoceranib/camrelizumab in the first line in unresectable or metastatic ...

Researchers at Weill Cornell Medicine have made a breakthrough in the fight against liver cancer, by identifying a biomarker ...

A group of researchers at VCU Massey Comprehensive Cancer Center was awarded $13 million by the National Cancer Institute.

Biomarker NBR1 shows promise in predicting liver cancer patients' response to immunotherapy, potentially improving treatment ...

Liver cancer cases continue to rise in England. This comes as NHS data, published this week, reveals a 5.4 percent increase ...

It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit ...

Researchers found that patients diagnosed with HCC during 2013-2019 were less likely to die from HCC or from any cause than patients who were diagnosed during 2006-2012.

From “Boy Meets World” actress Danielle Fishel discussing her breast cancer surgery to a young TikTok star dying from a rare ...

Liver cancer is the sixth leading cause cancer death in the U.S. The most common type of liver cancer in adults is ...

According to a preclinical study conducted by Weill Cornell Medicine researchers, it may soon be feasible to detect whether ...